423 related articles for article (PubMed ID: 27334457)
21. Successful control of poliomyelitis by a combined OPV/IPV polio vaccine program in the West Bank and Gaza, 1978-93.
Tulchinsky T; Abed Y; Handsher R; Toubassi N; Acker C; Melnick J
Isr J Med Sci; 1994; 30(5-6):489-94. PubMed ID: 8034509
[TBL] [Abstract][Full Text] [Related]
22. Anomalous observations on IPV and OPV vaccination.
John TJ
Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
[TBL] [Abstract][Full Text] [Related]
23. Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis.
Swartz TA; Handsher R; Manor Y; Stoeckel P; Barkay A; Mendelson E; Leventhal A
Vaccine; 1998 Dec; 16(20):2090-5. PubMed ID: 9796069
[TBL] [Abstract][Full Text] [Related]
24. Fractional-Dose Inactivated Poliovirus Vaccine Immunization Campaign - Telangana State, India, June 2016.
Bahl S; Verma H; Bhatnagar P; Haldar P; Satapathy A; Kumar KN; Horton J; Estivariz CF; Anand A; Sutter R
MMWR Morb Mortal Wkly Rep; 2016 Aug; 65(33):859-63. PubMed ID: 27559683
[TBL] [Abstract][Full Text] [Related]
25. Progress toward poliomyelitis eradication--Nigeria, January 2007-August 12, 2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Aug; 57(34):942-6. PubMed ID: 18756194
[TBL] [Abstract][Full Text] [Related]
26. Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India.
Chowdhary R; Dhole TN
J Med Virol; 2008 Aug; 80(8):1477-88. PubMed ID: 18551602
[TBL] [Abstract][Full Text] [Related]
27. Trade-offs of different poliovirus vaccine options for outbreak response in the United States and other countries that only use inactivated poliovirus vaccine (IPV) in routine immunization.
Thompson KM; Kalkowska DA; Kidd SE; Burns CC; Badizadegan K
Vaccine; 2024 Feb; 42(4):819-827. PubMed ID: 38218668
[TBL] [Abstract][Full Text] [Related]
28. Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine - Worldwide, 2013-2016.
Immunization Systems Management Group of the Global Polio Eradication Initiative
MMWR Morb Mortal Wkly Rep; 2015 Jul; 64(25):699-702. PubMed ID: 26135591
[TBL] [Abstract][Full Text] [Related]
29. How many OPV rounds are required to stop wild polio virus circulation in a developed country? Lessons from the Israeli experience.
Tasher D; Rahav G; Levine H; Sofer D; Linder N; Anis E; Shohat T; Manor Y; Kopel E; Shulman LM; Mendelson E; Shalit I; Somekh E
Vaccine; 2016 Jan; 34(3):299-301. PubMed ID: 26679402
[No Abstract] [Full Text] [Related]
30. Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation.
Duintjer Tebbens RJ; Thompson KM
J Infect Dis; 2014 Nov; 210 Suppl 1():S485-97. PubMed ID: 25316871
[TBL] [Abstract][Full Text] [Related]
31. The challenge of changing the inactivated poliomyelitis vaccine in Latin America: declaration of the Latin American Society of Pediatric Infectious Diseases (SLIPE).
Falleiros-Arlant LH; Avila-Agüero ML; Brea del Castillo J; Mariño C
Rev Chilena Infectol; 2014 Oct; 31(5):590-603. PubMed ID: 25491459
[TBL] [Abstract][Full Text] [Related]
32. Eradication of poliomyelitis in the United States.
Nathanson N
Rev Infect Dis; 1982; 4(5):940-50. PubMed ID: 7146731
[TBL] [Abstract][Full Text] [Related]
33. Coverage estimates and patterns of inactivated poliovirus vaccine (IPV) use prior to and during the polio eradication endgame, Jinan City, China, 2010-2015.
Chang C; Zhang J; Zhou J; Cao R; Song K; Liu C; Zhang X; Geng X; Liu X; Li C
Hum Vaccin Immunother; 2016 Nov; 12(11):2749-2752. PubMed ID: 27437792
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of the silent polio outbreak in Rahat, Israel, based on modeling of environmental surveillance data.
Brouwer AF; Eisenberg JNS; Pomeroy CD; Shulman LM; Hindiyeh M; Manor Y; Grotto I; Koopman JS; Eisenberg MC
Proc Natl Acad Sci U S A; 2018 Nov; 115(45):E10625-E10633. PubMed ID: 30337479
[TBL] [Abstract][Full Text] [Related]
35. A ten-year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas.
Tulchinsky T; Abed Y; Shaheen S; Toubassi N; Sever Y; Schoenbaum M; Handsher R
Am J Public Health; 1989 Dec; 79(12):1648-52. PubMed ID: 2817193
[TBL] [Abstract][Full Text] [Related]
36. Fractional-Dose Inactivated Poliovirus Vaccine Campaign - Sindh Province, Pakistan, 2016.
Pervaiz A; Mbaeyi C; Baig MA; Burman A; Ahmed JA; Akter S; Jatoi FA; Mahamud A; Asghar RJ; Azam N; Shah MN; Laghari MA; Soomro K; Wadood MZ; Ehrhardt D; Safdar RM; Farag N
MMWR Morb Mortal Wkly Rep; 2017 Dec; 66(47):1295-1299. PubMed ID: 29190264
[TBL] [Abstract][Full Text] [Related]
37. Characterization of outbreak response strategies and potential vaccine stockpile needs for the polio endgame.
Duintjer Tebbens RJ; Pallansch MA; Wassilak SG; Cochi SL; Thompson KM
BMC Infect Dis; 2016 Mar; 16():137. PubMed ID: 27009272
[TBL] [Abstract][Full Text] [Related]
38. Community engagement and integrated health and polio immunisation campaigns in conflict-affected areas of Pakistan: a cluster randomised controlled trial.
Habib MA; Soofi S; Cousens S; Anwar S; Haque NU; Ahmed I; Ali N; Tahir R; Bhutta ZA
Lancet Glob Health; 2017 Jun; 5(6):e593-e603. PubMed ID: 28495264
[TBL] [Abstract][Full Text] [Related]
39. Poliomyelitis outbreak in Israel in 1988: a report with two commentaries.
Slater PE; Orenstein WA; Morag A; Avni A; Handsher R; Green MS; Costin C; Yarrow A; Rishpon S; Havkin O
Lancet; 1990 May; 335(8699):1192-5; discussion 1196-8. PubMed ID: 1971043
[TBL] [Abstract][Full Text] [Related]
40. Strategic Response to an Outbreak of Circulating Vaccine-Derived Poliovirus Type 2 - Syria, 2017-2018.
Mbaeyi C; Wadood ZM; Moran T; ; Ather F; Stehling-Ariza T; Nikulin J; Al Safadi M; Iber J; Zomahoun L; Abourshaid N; Pang H; Collins N; Asghar H; Butt OUI; Burns CC; Ehrhardt D; Sharaf M
MMWR Morb Mortal Wkly Rep; 2018 Jun; 67(24):690-694. PubMed ID: 29927908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
